ArticleCardiovascular toxicology2024

Myocarditis Following Pembrolizumab Plus Axitinib, and Belzutifan Plus Lenvatinib for Renal Cell Carcinoma: A Case Report.

Andrea Villatore et al.PubMed ↗Publisher ↗

No numbers read from the abstract.